• Liposomal itraconazole formulation for the treatment of glioblastoma using inclusion complex with HP...

• Yoon Sung-Won

• Shin Dae-Hwan, Kim Jin-Seok

• Journal of Pharmaceutical Investigation   2019  Volume.49  No.4 477 ~ 483

• Long acting injectable formulations: the state of the arts and challenges of poly(lactic-co-glycolic...

• Lee Won-Young

• Asadujjaman Md., Jee Jun-Pil

• Journal of Pharmaceutical Investigation   2019  Volume.49  No.4 459 ~ 476

• PEGylated polylactide (PLA) and poly (lactic-co-glycolic acid) (PLGA) copolymers for the design of d...

• Perinelli Diego Romano

• Cespi Marco, Bonacucina Giulia, Palmieri Giovanni Filippo

• Journal of Pharmaceutical Investigation   2019  Volume.49  No.4 443 ~ 458

• Poly(lactic acid)/poly(lactic-co-glycolic acid) particulate carriers for pulmonary drug delivery

• Emami Fakhrossadat

• Yazdi Seyed Jamaleddin Mostafavi, Na Dong-Hee

• Journal of Pharmaceutical Investigation   2019  Volume.49  No.4 427 ~ 442

• PLA/PLGA nanoparticles prepared by nano spray drying

• Arpagaus Cordin

• Journal of Pharmaceutical Investigation   2019  Volume.49  No.4 405 ~ 426

• Meeting the unmet: from traditional to cutting-edge techniques for poly lactide and poly lactide-co-...

• Schoubben Aurelie

• Ricci Maurizio, Giovagnoli Stefano

• Journal of Pharmaceutical Investigation   2019  Volume.49  No.4 381 ~ 404

• Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-gly...

• Elmowafy Enas M.

• Tiboni Mattia, Soliman Mahmoud E.

• Journal of Pharmaceutical Investigation   2019  Volume.49  No.4 347 ~ 380

• Poly(lactic acid)/poly(lactic-co-glycolic acid)-based microparticles: an overview

• Blasi Paolo

• Journal of Pharmaceutical Investigation   2019  Volume.49  No.4 337 ~ 346